Sarcopenic obesity predicts nonremission of late-life depression.

Autor: Kokkeler KJE; Department of Old Age Psychiatry, ProPersona, Wolfheze/ Ede, The Netherlands.; University Center of Psychiatry & Interdisciplinary Center for Psychopathology of Emotion Regulation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van den Berg KS; University Center of Psychiatry & Interdisciplinary Center for Psychopathology of Emotion Regulation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Psychiatry, St Antonius Hospital, Utrecht, The Netherlands., Comijs HC; GGZinGeest/Department Psychiatry/Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands., Oude Voshaar RC; University Center of Psychiatry & Interdisciplinary Center for Psychopathology of Emotion Regulation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Marijnissen RM; Department of Old Age Psychiatry, ProPersona, Wolfheze/ Ede, The Netherlands.; University Center of Psychiatry & Interdisciplinary Center for Psychopathology of Emotion Regulation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Jazyk: angličtina
Zdroj: International journal of geriatric psychiatry [Int J Geriatr Psychiatry] 2019 Aug; Vol. 34 (8), pp. 1226-1234. Date of Electronic Publication: 2019 May 10.
DOI: 10.1002/gps.5121
Abstrakt: Background/objectives: Aging-related physiological changes like metabolic dysregulation and physical frailty are associated with depression and worsen its prognosis. Since central obesity is a key component of the metabolic syndrome and sarcopenia of physical frailty, we examined the association of sarcopenic obesity with depression cross-sectional and over time.
Methods: Cohort study of depressed patients and a nondepressed comparison group.
Setting: Primary and secondary mental health care.
Participants: Three hundred seventy-eight older (≥60 y) depressed patients of which 285 were followed up at 2 years and 132 nondepressed persons participating in the Netherlands Study of Depression in Older (NESDO) persons.
Measurements: Sarcopenic obesity was based on predefined cutoffs for both maximum handgrip strength (assessed with a dynamometer) and waist circumference (dichotomous) as well as the product term of handgrip strength by waist circumference (dimensional). Depressive disorder according to DSM-IV-TR criteria was assessed with fully structured psychiatric interview at baseline and 2-year follow-up.
Results: Sarcopenic obesity was more prevalent among depressed patients compared with nondepressed participants (18.9% versus 10.7%, P = 0.030). Neither the dichotomous nor dimensional operationalization of sarcopenic obesity was associated with baseline depressive disorder when adjusted for covariates. Nonetheless, among depressed patients, logistic regression showed that the interaction of handgrip strength by waist circumference was associated with remitted depression at 2-year follow-up (P = 0.044). Only among patients with a low handgrip strength, a higher waist circumference predicted nonremission.
Conclusion: Among depressed patients, sarcopenic obesity predicts nonremission of depression. Therefore, combined exercise and nutritional interventions might be effective for depressed patients with sarcopenic obesity.
(© 2019 John Wiley & Sons, Ltd.)
Databáze: MEDLINE
Externí odkaz: